The effects of bisphenol A (BPA) exposure on fat mass and serum leptin concentrations have no impact on bone mineral densities in non-obese premenopausal women

Clinical Biochemistry

Volumn 45, Issue 18, 2012, Pages 1602-1606

  Zhao, Hong Yan ^a   Bi, Yu Fang ^a   Ma, Lin Ying ^a   Zhao, Lin ^a   Wang, Tian Ge ^a   Zhang, Lian Zhen ^a   Tao, Bei ^a   Sun, Li Hao ^a   Zhao, Yong Ju ^a   Wang, Wei Qing ^a   Li, Xiao Yin ^a   Xu, Man Yin ^a   Chen, Jia Lun ^a   Ning, Guang ^a   Liu, Jian Min ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

BMD; BPA; Fat mass; Fat free mass; Leptin

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ESTRADIOL; LEPTIN; OSTEOCALCIN;

ADULT; AGE; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; BONE DENSITY; DRUG EFFECT; DRUG URINE LEVEL; ESTRADIOL BLOOD LEVEL; FEMALE; FEMUR NECK; HUMAN; HUMAN EXPERIMENT; LUMBAR SPINE; MENSTRUAL CYCLE; NORMAL HUMAN; OSSIFICATION; OSTEOLYSIS; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADIPOSITY; ADULT; BENZHYDRYL COMPOUNDS; BIOLOGICAL MARKERS; BODY COMPOSITION; BONE AND BONES; BONE DENSITY; ENVIRONMENTAL EXPOSURE; ESTRADIOL; FEMALE; HUMANS; LEPTIN; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; PHENOLS; PREMENOPAUSE; REGRESSION ANALYSIS; YOUNG ADULT;

EID: 84870693392     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2012.08.024     Document Type: Article

References (35)

1. Vandenberg L.N., Maffini M.V., Sonnenschein C., Rubin B.S., Soto A.M. Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr Rev 2009, 30:75-95.
2. Alonso-Magdalena P., Vieira E., Soriano S., Menes L., Burks D., Quesada I., et al. Bisphenol a exposure during pregnancy disrupts glucose homeostasis in mothers and adult male offspring. Environ Health Perspect 2010, 118:1243-1250.
3. Rubin B.S., Soto A.M. Bisphenol A: perinatal exposure and body weight. Mol Cell Endocrinol 2009, 304:55-62.
4. Ropero A.B., Alonso-Magdalena P., Garcia-Garcia E., Ripoll C., Fuentes E., Nadal A. Bisphenol-A disruption of the endocrine pancreas and blood glucose homeostasis. Int J Androl 2008, 31:194-200.
5. Wei J., Lin Y., Li Y., Ying C., Chen J., Song L., et al. Perinatal exposure to bisphenol a at reference dose predisposes offspring to metabolic syndrome in adult rats on a high-fat diet. Endocrinology 2011, 152:3049-3061.
6. Ning G., Bi Y., Wang T., Xu M., Xu Y., Huang Y., et al. Relationship of urinary bisphenol A concentration to risk for prevalent type 2 diabetes in chinese adults: a cross-sectional analysis. Ann Intern Med 2011, 155:368-374.
7. Carwile J.L., Michels K.B. Urinary bisphenol A and obesity: NHANES 2003-2006. Environ Res 2011, 111:825-830.
8. Patisaul H.B., Jefferson W. The pros and cons of phytoestrogens. Front Neuroendocrinol 2010, 31:400-419.
9. Rubin B.S., Murray M.K., Damassa D.A., King J.C., Soto A.M. Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma lh levels. Environ Health Perspect 2001, 109:675-680.
10. Bloom M.S., Kim D., Vom Saal F.S., Taylor J.A., Cheng G., Lamb J.D., et al. Bisphenol A exposure reduces the estradiol response to gonadotropin stimulation during in vitro fertilization. Fertil Steril 2011, 96:672-677. [e2].
11. Toda K., Miyaura C., Okada T., Shizuta Y. Dietary bisphenol A prevents ovarian degeneration and bone loss in female mice lacking the aromatase gene (cyp19). Eur J Biochem 2002, 269:2214-2222.
12. Seidlova-Wuttke D., Jarry H., Wuttke W. Pure estrogenic effect of benzophenone-2 (BP2) but not of bisphenol A (BPA) and dibutylphtalate (DBP) in uterus, vagina and bone. Toxicology 2004, 205:103-112.
13. Saarelainen J., Kiviniemi V., Kroger H., Tuppurainen M., Niskanen L., Jurvelin J., et al. Body mass index and bone loss among postmenopausal women: the 10-year follow-up of the ostpre cohort. J Bone Miner Metab 2012, 30:208-216.
14. Liu J.M., Zhao H.Y., Ning G., Zhao Y.J., Zhang L.Z., Sun L.H., et al. Relationship between body composition and bone mineral density in healthy young and premenopausal chinese women. Osteoporos Int 2004, 15:238-242.
15. Wang M.C., Bachrach L.K., Van Loan M., Hudes M., Flegal K.M., Crawford P.B. The relative contributions of lean tissue mass and fat mass to bone density in young women. Bone 2005, 37:474-481.
16. Bakker I., Twisk J.W., Van Mechelen W., Kemper H.C. Fat-free body mass is the most important body composition determinant of 10-yr longitudinal development of lumbar bone in adult men and women. J Clin Endocrinol Metab 2003, 88:2607-2613.
17. Karsenty G., Oury F. Biology without walls: the novel endocrinology of bone. Annu Rev Physiol 2012, 74:87-105.
18. Elefteriou F., Takeda S., Ebihara K., Magre J., Patano N., Kim C.A., et al. Serum leptin level is a regulator of bone mass. Proc Natl Acad Sci U S A 2004, 101:3258-3263.
19. Lee N.K., Karsenty G. Reciprocal regulation of bone and energy metabolism. Trends Endocrinol Metab 2008, 19:161-166.
20. Kwintkiewicz J., Nishi Y., Yanase T., Giudice L.C. Peroxisome proliferator-activated receptor-gamma mediates bisphenol A inhibition of FSH-stimulated IGF-1, aromatase, and estradiol in human granulosa cells. Environ Health Perspect 2010, 118:400-406.
21. Galloway T., Cipelli R., Guralnik J., Ferrucci L., Bandinelli S., Corsi A.M., et al. Daily bisphenol A excretion and associations with sex hormone concentrations: results from the inchianti adult population study. Environ Health Perspect 2010, 118:1603-1608.
22. Pelch K.E., Carleton S.M., Phillips C.L., Nagel S.C. Developmental exposure to low dose xenoestrogens alters femur length and tensile strength in adult mice. Biol Reprod 2012, 86:69.
23. Fu X., Ma X., Lu H., He W., Wang Z., Zhu S. Associations of fat mass and fat distribution with bone mineral density in pre- and postmenopausal chinese women. Osteoporos Int 2011, 22:113-119.
24. Lu L.J., Nayeem F., Anderson K.E., Grady J.J., Nagamani M. Lean body mass, not estrogen or progesterone, predicts peak bone mineral density in premenopausal women. J Nutr 2009, 139:250-256.
25. Bredella M.A., Torriani M., Ghomi R.H., Thomas B.J., Brick D.J., Gerweck A.V., et al. Determinants of bone mineral density in obese premenopausal women. Bone 2011, 48:748-754.
26. Chou W.C., Chen J.L., Lin C.F., Chen Y.C., Shih F.C., Chuang C.Y. Biomonitoring of bisphenol a concentrations in maternal and umbilical cord blood in regard to birth outcomes and adipokine expression: a birth cohort study in taiwan. Environ Health 2011, 10:94.
27. Hugo E.R., Brandebourg T.D., Woo J.G., Loftus J., Alexander J.W., Ben-Jonathan N. Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes. Environ Health Perspect 2008, 116:1642-1647.
28. Hamrick M.W., Pennington C., Newton D., Xie D., Isales C. Leptin deficiency produces contrasting phenotypes in bones of the limb and spine. Bone 2004, 34:376-383.
29. Blain H., Vuillemin A., Guillemin F., Durant R., Hanesse B., de Talance N., et al. Serum leptin level is a predictor of bone mineral density in postmenopausal women. J Clin Endocrinol Metab 2002, 87:1030-1035.
30. Barbour K.E., Zmuda J.M., Boudreau R., Strotmeyer E.S., Horwitz M.J., Evans R.W., et al. The effects of adiponectin and leptin on changes in bone mineral density. Osteoporos Int 2012, 23:1699-1710.
31. Lee S.W., Jo H.H., Kim M.R., You Y.O., Kim J.H. Association between obesity, metabolic risks and serum osteocalcin level in postmenopausal women. Gynecol Endocrinol 2012, 28:472-477.
32. Schafer A.L., Sellmeyer D.E., Schwartz A.V., Rosen C.J., Vittinghoff E., Palermo L., et al. Change in undercarboxylated osteocalcin is associated with changes in body weight, fat mass, and adiponectin: parathyroid hormone (1-84) or alendronate therapy in postmenopausal women with osteoporosis (the path study). J Clin Endocrinol Metab 2011, 96:E1982-E1989.
33. Foresta C., Strapazzon G., De Toni L., Gianesello L., Calcagno A., Pilon C., et al. Evidence for osteocalcin production by adipose tissue and its role in human metabolism. J Clin Endocrinol Metab 2010, 95:3502-3506.
34. Wang T., Li M., Chen B., Xu M., Xu Y., Huang Y., et al. Urinary bisphenol A (BPA) concentration associates with obesity and insulin resistance. J Clin Endocrinol Metab 2012, 97:E223-E227.
35. Mahalingaiah S., Meeker J.D., Pearson K.R., Calafat A.M., Ye X., Petrozza J., et al. Temporal variability and predictors of urinary bisphenol A concentrations in men and women. Environ Health Perspect 2008, 116:173-178.